Reducing inflammation could be the new weapon in the fight against cardio- vascular events. According to studies published an anti-inflammatory drug- Canakinumab- reduced the risk of heart attacks, stroke and death from cardio-vascular diseases.in people who already suffered a heart attack.The drug targets only inflammation and does not have any effect on cholesterol levels.
The study conducted on patients who already had a heart attack and high levels of a marker of inflammation in their blood- to get a placebo or one of three doses of canakinumab for 4 years. Those who had the drug had 15% lower risk of suffering a fatal or non-fatal heart attack or stroke compared to those who got the pacebo!.The drug also reduced the need for intervention such as angioplasty and bypass surgery by 30%.
_Mirror-